YD Bio Limited Ordinary Shares (YDES)

Health Care·equity

$6.73

+16.23% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

66/ 100

Score level

Above average

6 of 6 checks had data

How it compares with the broader market is one of its highest-scoring factors; business numbers score is on the low side; smart-money score is on the high side.

YDES scores higher than 93% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, YD Bio Limited Ordinary Shares (YDES) scores 66 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.37× 30-day average
52-week range: 1.70 – 22.00
Market cap: $155.83M
Earnings date: —

Volume: 207,611
Avg. volume (30d): 566,675

Open: 5.71
Previous close: 5.79
Day's range (regular session): 5.61 – 7.09

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: —
P/E (TTM): —
EPS (TTM): —

Score breakdown · six named factors

Price trend

Strength vs the market

100

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for YDES

5 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for YDES. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about YDES right now

YD Bio Limited Ordinary Shares (YDES) currently scores 66/100 on the Market Census six-factor composite, at the Above average score level. YDES is +16.23% on the day and -16.65% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for YDES leans good, with some weak spots. YDES's strongest factor is strength vs the market at 100/100 — a very strong read on how YDES has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See YDES in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score